Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2021 | How BMI influences endometrial cancer risk

Emma Hazelwood • 4 Nov 2021
NCRI 2021
Endometrial Cancer Gynecological Cancer Metformin

Emma Hazelwood, MSc, University of Bristol, Bristol, UK, discusses the molecular mediators of the relationship between body mass index (BMI) and endometrial cancer risk. A Mendelian randomization analysis was carried out, which analyzed germline genetic variants to assess causal relationships. 14 potential mediators were identified, with fasting insulin, bioavailable testosterone, and sex hormone binding globulin (SHBG) being factors that mediated the link between BMI and endometrial cancer the most. This interview took place at the National Cancer Research Institute (NCRI) Festival 2021.

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals